Visx Advances

ImClone jumps, Fidelity National moves higher; plus more of today's stocks in the news

The FDA approved Visx 's (EYE ) CustomVue laser vision correction. Wachovia reiterates outperform.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.